Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis

Eltrombopag is an orally administered, non-peptide, thrombopoietin receptor agonist which initiates thrombopoietin signaling and stimulates the production of normally functioning platelet. We aimed to do a systematic review and meta-analysis of currently available published data to verify whether el...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Hafiz Abdul Waqas, Masoud, Ahmed Taher, Han, Jia, Adel Sofy, Ahmed, Saeed Ahmed, Ahmed, Abdesattart, Ahmed Taha, Drokow, Emmanuel Kwateng, Sun, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060759/
https://www.ncbi.nlm.nih.gov/pubmed/33874785
http://dx.doi.org/10.1177/10760296211005555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060759/
https://www.ncbi.nlm.nih.gov/pubmed/33874785
http://dx.doi.org/10.1177/10760296211005555

Ejemplares similares